相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alcohol consumption, cigarette smoking and cancer of unknown primary risk: Results from the Netherlands Cohort Study
Karlijn E. P. E. Hermans et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design
Jeffrey S. Ross et al.
ONCOLOGIST (2021)
Squamous cell carcinoma of the head and neck with unknown primary: trends and outcomes from a hospital-based registry
Michael A. Cummings et al.
ANNALS OF TRANSLATIONAL MEDICINE (2021)
Low Infiltration of CD8+PD-L1+T Cells and M2 Macrophages Predicts Improved Clinical Outcomes After Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Carcinoma
Liuning Li et al.
FRONTIERS IN ONCOLOGY (2021)
Impact of PD-L1 expression and human papillomavirus status in anti-PD1/PDL1 immunotherapy for head and neck squamous cell carcinoma-Systematic review and meta-analysis
Jaimin J. Patel et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2020)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Metastatic Cancer of Unknown Primary or Primary Metastatic Cancer?
Stefan Kolling et al.
FRONTIERS IN ONCOLOGY (2020)
Clinical efficacy and safety of anti-PD-1/PD-L1 inhibitors for the treatment of advanced or metastatic cancer: a systematic review and meta-analysis
Leitao Sun et al.
SCIENTIFIC REPORTS (2020)
Radiotherapeutic management of cervical lymph node metastases from an unknown primary site - experiences from a large cohort treated with modern radiation techniques
Tanja Sprave et al.
RADIATION ONCOLOGY (2020)
Insights from the genetic and transcriptional characterization of a cancer of unknown primary (CUP)
Veronica Davalos et al.
EMBO MOLECULAR MEDICINE (2020)
Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers
Attia M. Elbehi et al.
ORAL ONCOLOGY (2020)
A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany
Miriam Reuschenbach et al.
CANCER MEDICINE (2019)
Comprehensive management of HPV-related squamous cell carcinoma of the head and neck of unknown primary
Elie Rassy et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Elham Alsahafi et al.
CELL DEATH & DISEASE (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
Ezra E. W. Cohen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
The currently declining incidence of cancer of unknown primary
Elie Rassy et al.
CANCER EPIDEMIOLOGY (2019)
PD-L1 Distribution and Perspective for Cancer Immunotherapy-Blockade, Knockdown, or Inhibition
Yilun Wu et al.
FRONTIERS IN IMMUNOLOGY (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
Clinical and immune profiling for cancer of unknown primary site
Koji Haratani et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Molecular characterisation and liquid biomarkers in Carcinoma of Unknown Primary (CUP): taking the 'U' out of 'CUP'
Alicia-Marie Conway et al.
BRITISH JOURNAL OF CANCER (2019)
Immunological Agents Used in Cancer Treatment
Melih Simsek et al.
EURASIAN JOURNAL OF MEDICINE (2019)
AHNS Series: Do you know your guidelines? Guideline recommendations for head and neck cancer of unknown primary site
Antoine Eskander et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2018)
Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy
Zoran Gatalica et al.
EUROPEAN JOURNAL OF CANCER (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma
Eric Adjei Boakye et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)
Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
Peixin Dong et al.
FRONTIERS IN ONCOLOGY (2018)
Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges
Jens Mueller von der Gruen et al.
RADIATION ONCOLOGY (2017)
PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer
Benjamin A. Kansy et al.
CANCER RESEARCH (2017)
American Cancer Society Head and Neck Cancer Survivorship Care Guideline
Ezra E. W. Cohen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model
Kari Hemminki et al.
SCIENTIFIC REPORTS (2016)
Changes in Unknown Primary Squamous Cell Carcinoma of the Head and Neck at Initial Presentation in the Era of Human Papillomavirus
Kevin Motz et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
Human papillomavirus is a favourable prognostic factor in cancer of unknown primary in the head and neck region and in hypopharyngeal cancer (Review)
Lars Sivars et al.
MOLECULAR AND CLINICAL ONCOLOGY (2016)
Unknown primary of the head and neck: A long-term follow-up
Martin Lanzer et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2015)
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
New Strategies for Carcinoma of Unknown Primary: The Role of Tissue-of-Origin Molecular Profiling
Gauri Varadhachary
CLINICAL CANCER RESEARCH (2013)
Comprehensive Control of Human Papillomavirus Infections and Related Diseases
F. Xavier Bosch et al.
VACCINE (2013)
Cancer of unknown primary site
Nicholas Pavlidis et al.
LANCET (2012)
Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis
Kenzo Takada
SEMINARS IN CANCER BIOLOGY (2012)
Cancer of unknown primary site: Missing primary or missing biology?
George Pentheroudakis et al.
ONCOLOGIST (2007)
分享论文
